– ISRAEL, Netanya – CLEW, a provider of real-time AI analytics platforms for healthcare, today announced the appointment of Paul Roscoe as its new CEO, replacing co-founder Gal Salomon who will become Executive Chairman.
“Paul has an exemplary record of building and scaling organizations that deliver significant value to healthcare customers. He is an experienced and visionary leader who has operated in the US and European healthcare markets. His deep technology experience, and 20 years of healthcare domain knowledge, made him the stand-out candidate,” said founder and Executive Chairman, Gal Solomon.
About Paul Roscoe
Before joining CLEW, Paul Roscoe was CEO of Trinda Health, responsible for establishing the company as the industry leader in quality-oriented clinical documentation solutions. Mr. Roscoe was also CEO, Co-Founde,r and Board Member of Docent Health, where he launched, capitalized, and commercialized the business, resulting in the company being recognized as one of the most innovative and successful solutions in the growing healthcare CRM/patient engagement segment.
Previously, Mr. Roscoe served as the CEO of Crimson, a division of the Advisory Board Company, and led the business to become the de-facto standard healthcare analytics company in the US healthcare market. Before Crimson, he was General Manager of Microsoft’s Healthcare Solutions Group. Mr. Roscoe joined Microsoft after the acquisition of Sentillion, where he served as President and led the business to become the industry leader in Healthcare Identity Management. Throughout his career, Mr. Roscoe has held numerous executive and management roles at healthcare technology companies, including VisionWare Inc., Sybase, and New Era of Networks (acquired by Sybase).
“Healthcare systems are faced with enormous challenges of workforce burnout, increasing severity of patient illness, longer lengths of stay, and capacity shortages. CLEW’s FDA-approved approach to delivering AI-powered technology, and workflows to aid the decision-making and quality of care within the ICU, is unique in the market. Gal and the team have built a world-class company, and I am excited for the next chapter of its growth,” said Paul Roscoe.
CLEW provides real-time AI analytics platforms designed to help providers make better-informed clinical decisions by predicting life-threatening complications across various medical care settings. CLEW’s goal is to provide solutions that can improve outcomes and safety, streamline patient care, and efficiently handle regulations and penalties, ultimately lowering the cost of care. Originally developed and proven in the ICU, CLEW will develop machine learning models that have the potential to optimize clinical resources and guide healthcare providers in predicting patient deterioration across all care settings.
For more information: https://clewmed.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.